Gene: ACAT1
Official Full Name: acetyl-CoA acetyltransferase 1provided by HGNC
Gene Summary: This gene encodes a mitochondrially localized enzyme that catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA. Defects in this gene are associated with 3-ketothiolase deficiency, an inborn error of isoleucine catabolism characterized by urinary excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, tiglylglycine, and butanone. [provided by RefSeq, Feb 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06756 | ACAT1 Knockout cell line (HeLa) | Human | ACAT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06757 | ACAT1 Knockout cell line (HCT 116) | Human | ACAT1 | 1:2~1:4 | Negative | Online Inquiry |
KO06758 | ACAT1 Knockout cell line (HEK293) | Human | ACAT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06759 | ACAT1 Knockout cell line (A549) | Human | ACAT1 | 1:3~1:4 | Negative | Online Inquiry |
ACAT1 Gene Knockout Cell Lines represent a pivotal innovation in the realm of cellular research, specifically designed to facilitate the investigation of acetyl-CoA acyltransferase 1 (ACAT1) gene functions. By employing CRISPR/Cas9 gene-editing technology, these cell lines exhibit a complete inactivation of the ACAT1 gene, which plays a crucial role in cholesterol metabolism and lipid homeostasis. This knockout allows researchers to explore the subsequent biological pathways affected by ACAT1 absence, enabling a deeper understanding of its contributions to various metabolic disorders.
The primary mechanisms of action at play involve the blockade of ACAT1 activity, leading to altered intracellular levels of cholesteryl esters and free fatty acids. This disruption can significantly impact cellular functions such as apoptosis, proliferation, and inflammatory responses, findings that can be further investigated using these specific cell lines. The resulting phenotypic variations provide an invaluable platform for researchers examining metabolic syndromes, cardiovascular diseases, and potential therapeutic avenues targeting lipid metabolism.
In terms of scientific importance, ACAT1 Gene Knockout Cell Lines are indispensable in both research and clinical settings. They supply critical insights into the mechanisms underlying diseases associated with lipid dysregulation, offering a therapeutic target for drug discovery. Unique selling points include the precise gene editing, consistency in cellular behavior, and adaptability to various experimental frameworks, distinguishing these cell lines from traditional wild-type models.
By leveraging ACAT1 Gene Knockout Cell Lines, researchers and clinicians can enhance their investigations with a focus on specific pathways affected by ACAT1 deficiency. This innovation not only elevates the standard of research but also paves the way for advanced therapeutic strategies tailored to meet clinical needs.
At our company, we pride ourselves on delivering high-quality biological products that push the boundaries of scientific discovery. By offering ACAT1 Gene Knockout Cell Lines, we empower researchers to make significant strides in understanding lipid metabolism and its implications for human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.